Human growth hormone (hGH) therapy is one of the most talked about "youth" therapies available today. Allure magazine, in its "Anti-aging Special" issue, highlighted growth hormone as its 2013 call-out. Shape magazine began a recent growth ...
Tags: Light Industry, Daily Use
US-based biotechnology firm BioTime has entered into a sublicense agreement with Jade Therapeutics, a developer of ophthalmic sustained-release drug delivery platforms, for ophthalmic drug delivery applications of BioTime's HyStem ...
Tags: Health, Medicine, biotechnology
You probably wouldn't expect the topic of human growth hormone (hGH) to cause an uproar at one of the most prestigious cosmetic dermatology conferences in the world. But at the International Academy of Cosmetic Dermatology's 9th World ...
SanMedica International™ has plans to reveal a cutting-edge new product that, according to the company, will help consumers battle the OTHER cause of wrinkles. "Everyone knows about sun damage, and beauty companies are always ...
Tags: Wrinkles
NEW YORK, June 7, 2013 /PRNewswire/ -- For weeks, speculation has been building about the "anti-aging" event SanMedica International™ is hosting in Las Vegas from June 7-9. The event will be held at The Palazzo — one of Vegas's ...
The European Commission and the European Medicines Agency have issued orphan drug designation to PROLOR Biotech's hGH-CTP. The longer-acting version of human growth hormone, hGH-CTP, is being developed to treat growth hormone deficiency. ...
Tags: PROLOR Biotech, hGH-CTP, European Orphan Drug Designation
Biotech has rceived a notice of allowance from the USPTO for a patent application covering the company's long-acting CTP-enhanced human growth hormone (hGH-CTP). Once the patent is issued, PROLOR would gain additional intellectual ...
Tags: PROLOR, CTP platform, human growth hormone
BioTime has signed an exclusive sublicense agreement and a supply agreement with Jade Therapeutics for ophthalmological drug delivery applications of HyStem technology. According to the agreement, BioTime will provide Jade with ...
Tags: HyStem technology, Biotime, Jade Therapeutics, ophthalmological drug